
CellCrine
BAP* a youthful protein + Basal media, outperforms FBS across all cell types tested to date.
About CellCrine
BAP Chemically Defined Supplement (BAP-CDS) outperforms Fetal Bovine Serum (FBS).
Recent Funding lists CellCrine under Health and bio (also Manufacturing and industrial). It went through IndieBio (IndieBio SF 12).
Funding rounds
- Website created
- IndieBio SF 12
IIndieBio · batchSource: indiebio.co
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
CellCrine: questions and answers
- Who invested in CellCrine?
- Investors on record for CellCrine: IndieBio.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cellcrine (get a free API key).